First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV367
Clinical trial NCT05507970 · COMPLETED
Trial details
- NCT number
- NCT05507970
- Sponsor
- Medicines for Malaria Venture
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-29
- Primary completion
- 2023-01-25
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.